Cognitive modifications associated with tobacco smoking;Altérations cognitives liées au tabac

Presse Medicale

Volumn 38, Issue 9, 2009, Pages 1241-1252

  Lecacheux, Marie ^a   Karila, Laurent ^a   Aubin, Henri Jean ^a   Dupont, Patrick ^a   Benyamina, Amine ^a   Maman, Judith ^a   Lebert, Amandine ^a   Reynaud, Michel ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; COGNITIVE DEFECT; DEMENTIA; HUMAN; MEDICAL LITERATURE; MEDLINE; MEMORY; MENTAL PERFORMANCE; MENTAL TEST; NEUROPROTECTION; OUTCOME ASSESSMENT; PSYCINFO; RISK ASSESSMENT; SMOKING;

EID: 69549130590     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2009.01.017     Document Type: Article

References (78)

1. Guilbert P., and Gauthier A. Baromètre Santé 2005 (2006), INPES, Paris
2. Checkoway H., Powers K., Smith-Weller T., Franklin G.M., Longstreth Jr. W.T., and Swanson P.D. Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol 155 (2002) 732-738
3. Lee P.N. Smoking and Alzheimer's disease: a review of the epidemiological evidence. Neuroepidemiology 13 (1994) 131-144
4. Van Duijn C.M., Clayton D.G., Chandra V., Fratiglioni L., Graves A.B., Heyman A., et al. Interaction between genetic and environmental risk factors for Alzheimer's disease : a reanalysis of case-control studies. EURODEM Risk Factors Research Group. Genet Epidemiol 11 (1994) 539-551
5. OFDT. Bilan de l'année 2007. Tableau de bord mensuel des indicateurs tabac 2008. http://www.ofdt.fr/ofdtdev/live/donneesnat/tabtabac.html.
6. Legleye S., Spilka S., and Beck F. Le tabagisme des adolescents en France, suite aux récentes des prix. Bull Epidemiol Hebd 21/22 (2006) 150-152
7. Swan G.E., and Lessov-Schlaggar C.N. The effects of tobacco smoke and nicotine on cognition and the brain. Neuropsychol Rev 17 (2007) 259-273
8. Heishman S.J., and Henningfield J.E. Tolerance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers. Psychopharmacology (Berl) 152 (2000) 321-333
9. Bechara A., Dolan S., and Hindes A. Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward?. Neuropsychologia 40 (2002) 1690-1705
10. Marlatt G.A., and Donovan D.M. Relapse prevention: maintenance strategies in the treatment of addictive behaviours (2005), Guilford Press, New York
11. Xiao L., Bechara A., Cen S., Grenard J.L., Stacy A.W., Gallaher P., et al. Affective decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in 10th-grade Chinese adolescent smokers. Nicotine Tob Res 10 (2008) 1085-1097
12. Baker F., Johnson M.W., and Bickel W.K. Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude. J Abnorm Psychol 112 (2003) 382-392
13. Bickel W.K., Odum A.L., and Madden G.J. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl) 146 (1999) 447-454
14. Mitchell S.H. Measures of impulsivity in cigarette smokers and nonsmokers. Psychopharmacol (Berl) 146 (1999) 455-464
15. Field M., Santarcangelo M., Sumnall H., Goudie A., and Cole J. Delay discounting and the behavioural economics of cigarette purchases in smokers: the effects of nicotine deprivation. Psychopharmacology (Berl) 186 (2006) 255-263
16. Field M., Rush M., Cole J., and Goudie A. The smoking Stroop and delay discounting in smokers: effects of environmental smoking cues. J Psychopharmacol 21 (2007) 603-610
17. Parrott A.C., and Craig D. Cigarette smoking and nicotine gum (0,2 and 4 mg): effects upon four visual attention tasks. Neuropsychobiology 25 (1992) 34-43
18. Zack M., Belsito L., Scher R., Eissenberg T., and Corrigall W.A. Effects of abstinence and smoking on information processing in adolescent smokers. Psychopharmacology (Berl) 153 (2001) 249-257
19. Dinn W.M., Aycicegi A., and Harris C.L. Cigarette smoking in a student sample: neurocognitive and clinical correlates. Addict Behav 29 (2004) 107-126
20. Munafo M., Mogg K., Roberts S., Bradley B.P., and Murphy M. Selective processing of smoking-related cues in current smokers, ex-smokers and never-smokers on the modified Stroop task. J Psychopharmacol 17 (2003) 310-316
21. Ernst M., Heishman S.J., Spurgeon L., and London E.D. Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology 25 (2001) 313-319
22. Foulds J., Stapleton J., Swettenham J., Bell N., McSorley K., and Russell M.A. Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers. Psychopharmacology (Berl) 127 (1996) 31-38
23. Levin E.D., Conners C.K., Silva D., Hinton S.C., Meck W.H., March J., et al. Transdermal nicotine effects on attention. Psychopharmacology (Berl) 140 (1998) 135-141
24. Pritchard W.S., Robinson J.H., and Guy T.D. Enhancement of continuous performance task reaction time by smoking in non-deprived smokers. Psychopharmacology (Berl) 108 (1992) 437-442
25. Levin E.D., Conners C.K., Sparrow E., Hinton S.C., Erhardt D., Meck W.H., et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology (Berl) 123 (1996) 55-63
26. Newhouse P.A., Potter A., and Levin E.D. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11 (1997) 206-228
27. Levin E.D., Wilson W., Rose J.E., and McEvoy J. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15 (1996 Nov) 429-436
28. Smith R.C., Warner-Cohen J., Matute M., Butler E., Kelly E., Vaidhyanathaswamy S., et al. Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology 31 (2006) 637-643
29. Kelton M.C., Kahn H.J., Conrath C.L., and Newhouse P.A. The effects of nicotine on Parkinson's disease. Brain Cogn 43 (2000) 274-282
30. Lemay S., Chouinard S., Blanchet P., Masson H., Soland V., Beuter A., et al. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 31-39
31. Brody A.L. Functional brain imaging of tobacco use and dependence. J Psychiatr Res 40 (2006) 404-418
32. Ilan A.B., and Polich J. Tobacco smoking and event-related brain potentials in a Stroop task. Int J Psychophysiol 40 (2001) 109-118
33. Rezvani A.H., and Levin E.D. Cognitive effects of nicotine. Biol Psychiatry 49 (2001) 258-267
34. Landers D.M., Crews D.J., Boutcher S.H., Skinner J.S., and Gustafsen S. The effects of smokeless tobacco on performance and psychophysiological response. Med Sci Sports Exerc 24 (1992) 895-903
35. Perkins K.A., Grobe J.E., Fonte C., Goettler J., Caggiula A.R., Reynolds W.A., et al. Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 270 (1994) 628-638
36. Phillips S., and Fox P. An investigation into the effects of nicotine gum on short-term memory. Psychopharmacology (Berl) 140 (1998) 429-433
37. Rusted J.M., and Trawley S. Comparable effects of nicotine in smokers and nonsmokers on a prospective memory task. Neuropsychopharmacology 31 (2006) 1545-1549
38. Newhouse P.A., Sunderland T., Tariot P.N., Blumhardt C.L., Weingartner H., Mellow A., et al. Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology (Berl) 95 (1988) 171-175
39. Smith R.C., Singh A., Infante M., Khandat A., and Kloos A. Effects of cigarette smoking and nicotine nasal spray on psychiatric symptoms and cognition in schizophrenia. Neuropsychopharmacology 27 (2002) 479-497
40. Sakurai Y., and Kanazawa I. Acute effects of cigarettes in non-deprived smokers on memory, calculation and executive functions. Hum Psychopharmacol 17 (2002) 369-373
41. Hindmarch I., Kerr J.S., and Sherwood N. Effects of nicotine gum on psychomotor performance in smokers and non-smokers. Psychopharmacology (Berl) 100 (1990) 535-541
42. Jacobsen L.K., Krystal J.H., Mencl W.E., Westerveld M., Frost S.J., and Pugh K.R. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol Psychiatry 57 (2005) 56-66
43. Galanis D.J., Petrovitch H., Launer L.J., Harris T.B., Foley D.J., and White L.R. Smoking history in middle age and subsequent cognitive performance in elderly Japanese-American men. The Honolulu-Asia Aging Study. Am J Epidemiol 145 (1997) 507-515
44. Aleman A., Muller M., de Haan E.H., and van der Schouw Y.T. Vascular risk factors and cognitive function in a sample of independently living men. Neurobiol Aging 26 (2005) 485-490
45. Muller M., Grobbee D.E., Aleman A., Bots M., and van der Schouw Y.T. Cardiovascular disease and cognitive performance in middle-aged and elderly men. Atherosclerosis 190 (2007) 143-149
46. Richards M., Jarvis M.J., Thompson N., and Wadsworth M.E. Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am J Public Health 93 (2003) 994-998
47. Ott A., Andersen K., Dewey M.E., Letenneur L., Brayne C., Copeland J.R., et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology 62 (2004) 920-924
48. Wang L., van Belle G., Kukull W.B., and Larson E.B. Predictors of functional change: a longitudinal study of nondemented people aged 65 and older. J Am Geriatr Soc 50 (2002) 1525-1534
49. Sabia S., Marmot M., Dufouil C., and Singh-Manoux A. Smoking history and cognitive function in middle age from the Whitehall II study. Arch Intern Med 168 (2008) 1165-1173
50. Knopman D., Boland L.L., Mosley T., Howard G., Liao D., Szklo M., et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56 (2001) 42-48
51. van Duijn C.M., and Hofman A. Relation between nicotine intake and Alzheimer's disease. BMJ 302 (1991) 1491-1494
52. Graves A.B., van Duijn C.M., Chandra V., Fratiglioni L., Heyman A., Jorm A.F., et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 20 Suppl 2 (1991) S48-57
53. Shalat S.L., Seltzer B., Pidcock C., and Baker Jr. E.L. Risk factors for Alzheimer's disease: a case-control study. Neurology 37 (1987) 1630-1633
54. Prince M., Cullen M., and Mann A. Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial. Neurology 44 (1994) 97-104
55. Hebert L.E., Scherr P.A., Beckett L.A., Funkenstein H.H., Albert M.S., Chown M.J., et al. Relation of smoking and alcohol consumption to incident Alzheimer's disease. Am J Epidemiol 135 (1992) 347-355
56. Ott A., Slooter A.J., Hofman A., van Harskamp F., Witteman J.C., Van Broeckhoven C., et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 351 (1998) 1840-1843
57. Tyas S.L., White L.R., Petrovitch H., Webster Ross G., Foley D.J., Heimovitz H.K., et al. Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study. Neurobiol Aging 24 (2003) 589-596
58. Juan D., Zhou D.H., Li J., Wang J.Y., Gao C., and Chen M. A 2-year follow-up study of cigarette smoking and risk of dementia. Eur J Neurol 11 (2004) 277-282
59. Luchsinger J.A., Reitz C., Honig L.S., Tang M.X., Shea S., and Mayeux R. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65 (2005) 545-551
60. Roman G.C. Vascular dementia prevention: a risk factor analysis. Cerebrovasc Dis 20 Suppl 2 (2005) 91-100
61. Meyer J.S., Rauch G.M., Crawford K., Rauch R.A., Konno S., Akiyama H., et al. Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia. Int J Geriatr Psychiatry 14 (1999) 1050-1061
62. Meyer J.S., Rauch G., Rauch R.A., and Haque A. Risk factors for cerebral hypoperfusion, mild cognitive impairment, and dementia. Neurobiol Aging 21 (2000) 161-169
63. Bowirrat A., Friedland R.P., Farrer L., Baldwin C., and Korczyn A. Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs. J Mol Neurosci 19 (2002) 239-245
64. Bhargava D., Weiner M.F., Hynan L.S., Diaz-Arrastia R., and Lipton A.M. Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J Geriatr Psychiatry Neurol 19 (2006) 78-82
65. Bechara A., Dolan S., Denburg N., Hindes A., Anderson S.W., and Nathan P.E. Decision-making deficits, linked to a dysfunctional ventromedial prefrontal cortex, revealed in alcohol and stimulant abusers. Neuropsychologia 39 (2001) 376-389
66. Bolla K.I., Eldreth D.A., London E.D., Kiehl K.A., Mouratidis M., Contoreggi C., et al. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage 19 (2003) 1085-1094
67. Bolla K.I., Eldreth D.A., Matochik J.A., and Cadet J.L. Neural substrates of faulty decision-making in abstinent marijuana users. Neuroimage 26 (2005) 480-492
68. Forman S.D., Dougherty G.G., Casey B.J., Siegle G.J., Braver T.S., Barch D.M., et al. Opiate addicts lack error-dependent activation of rostral anterior cingulate. Biol Psychiatry 55 (2004) 531-537
69. Lee A., Kannan V., and Hillis A.E. The contribution of neuroimaging to the study of language and aphasia. Neuropsychol Rev 16 (2006) 171-183
70. Solowij N., Stephens R.S., Roffman R.A., Babor T., Kadden R., Miller M., et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 287 (2002) 1123-1131
71. Kirisci L., Tarter R.E., Vanyukov M., Reynolds M., and Habeych M. Relation between cognitive distortions and neurobehavior disinhibition on the development of substance use during adolescence and substance use disorder by young adulthood: a prospective study. Drug Alcohol Depend 76 (2004) 125-133
72. Tarter R.E., Kirisci L., Mezzich A., Cornelius J.R., Pajer K., Vanyukov M., et al. Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder. Am J Psychiatry 160 (2003) 1078-1085
73. Paus T., Zijdenbos A., Worsley K., Collins D.L., Blumenthal J., Giedd J.N., et al. Structural maturation of neural pathways in children and adolescents: in vivo study. Science 283 (1999) 1908-1911
74. Giedd J.N., Blumenthal J., Jeffries N.O., Castellanos F.X., Liu H., Zijdenbos A., et al. Brain development during childhood and adolescence: a longitudinal MRI study. Nat Neurosci 2 (1999) 861-863
75. Jacobsen L.K., Pugh K.R., Mencl W.E., and Gelernter J. C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency. Psychopharmacology (Berl) 188 (2006) 530-540
76. Letenneur L., Larrieu S., and Barberger-Gateau P. Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies. Biomed Pharmacother 58 (2004) 95-99
77. Stella F., Banzato C.E., Gasparetto Se E.V., Scudeler J.L., Pacheco J.L., and Kajita R.T. Risk factors for vascular dementia in elderly psychiatric outpatients with preserved cognitive functions. J Neurol Sci 257 (2007) 247-249
78. Kalmijn S., van Boxtel M.P., Verschuren M.W., Jolles J., and Launer L.J. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. Am J Epidemiol 156 (2002) 936-944